Nanologica AB (publ) banner
N

Nanologica AB (publ)
STO:NICA

Watchlist Manager
Nanologica AB (publ)
STO:NICA
Watchlist
Price: 0.409 SEK 0.74%
Market Cap: kr36.1m

Relative Value

The Relative Value of one NICA stock under the Base Case scenario is hidden SEK. Compared to the current market price of 0.409 SEK, Nanologica AB (publ) is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NICA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

NICA Competitors Multiples
Nanologica AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Nanologica AB (publ)
STO:NICA
36.1m SEK 1.6 -0.8 -0.9 -0.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
400.6B USD 6.6 168.8 16.4 23.2
US
Amgen Inc
NASDAQ:AMGN
204B USD 5.5 26.4 15.1 15.1
US
Gilead Sciences Inc
NASDAQ:GILD
189B USD 6.4 22.2 15.1 15.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.3B USD 9.9 30.1 23 24
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.5B USD 5.8 18.4 14 15.9
AU
CSL Ltd
ASX:CSL
74.6B AUD 3.3 17.3 11.8 14.7
NL
argenx SE
XBRU:ARGX
44.2B EUR 14.5 34 58.5 60.1
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/S Multiple
Revenue Growth P/S to Growth
SE
N
Nanologica AB (publ)
STO:NICA
Average P/S: 3 058 675.2
1.6
106%
0
FR
Pharnext SCA
OTC:PNEXF
33 643 258.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
5.5
2%
2.8
US
Gilead Sciences Inc
NASDAQ:GILD
6.4
5%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
2 094
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.8
9%
0.6
AU
CSL Ltd
ASX:CSL
3.3
5%
0.7
NL
argenx SE
XBRU:ARGX
14.5
49%
0.3
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
SE
N
Nanologica AB (publ)
STO:NICA
Average P/E: 45.3
Negative Multiple: -0.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.8
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
26.4
18%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
22.2
14%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.1
17%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.4
13%
1.4
AU
CSL Ltd
ASX:CSL
17.3
11%
1.6
NL
argenx SE
XBRU:ARGX
34
42%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
N
Nanologica AB (publ)
STO:NICA
Average EV/EBITDA: 22
Negative Multiple: -0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.4
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
15.1
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.1
18%
0.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
15%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14
23%
0.6
AU
CSL Ltd
ASX:CSL
11.8
8%
1.5
NL
argenx SE
XBRU:ARGX
58.5
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
N
Nanologica AB (publ)
STO:NICA
Average EV/EBIT: 24
Negative Multiple: -0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
15.1
2%
7.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.1
11%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.9
21%
0.8
AU
CSL Ltd
ASX:CSL
14.7
11%
1.3
NL
argenx SE
XBRU:ARGX
60.1
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A